Dr Reddy's Laboratories launches cholesterol lowering drug in US

The drug is the generic version of MSD International's Vytorin (ezetimibe & simvastatin) tablet

Dr Reddy's completes acquisition of product portfolio from Teva

Premium

BS B2B Bureau Hyderabad

Last Updated : May 02 2017 | 1:29 PM IST

Dr Reddy’s Laboratories Ltd has launched cholesterol lowering drug - ezetimibe and simvastatin tablet in strengthens of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg - in the US. The drug is the generic version of MSD International GmbH’s Vytorin tablet. Dr Reddy’s is among the first companies to launch the generic product in the US market.

The Vytorin brand had US sales of approximately $ 678 million MAT for the most recent twelve months ended in February 2017 according to IMS Health. Vytorin reduces the levels of bad cholesterol (low-density lipoprotein, or LDL) and triglycerides

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in